Brought to you by 
Antares Pharma, Inc.
http://www.antarespharma.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Antares Pharma, Inc.
Takeda Sheds More Non-Core Assets, Employees In $670m Orifarm Deal
Danish firm picks up portfolio and manufacturing sites, along with around 600 employees.
Deal Watch: Molecular Templates Aligns With Vertex On Optimizing Stem Cell Candidates
Alliance with Molecular Templates may help advance efforts under Vertex’s existing collaboration with CRISPR Therapeutics. Dragonfly’s latest partner for its TriNKET platform is AbbVie.
Venture Funding Deals: Tenaya's $92m, Nuvation's $275m Lead October Rounds
Former Medivation CEO David Hung launched stealthy oncology start-up Nuvation with $275m in series A venture capital, while Tenaya's series B brought in $92m for small molecules as well as cell and gene therapies to treat cardiovascular diseases.
Stada Launches Propofol Pump In Australia Via BioQ Tie-Up
Stada is looking to add value to Australia’s anesthetics market by introducing BioQ Pharma’s ready-to-use Propofusor propofol device.
Company Information
- Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Topical Delivery
- Transdermal
- Other Names / Subsidiaries
-
- Medi-Ject Corporation
- Permatec